Detalles de la búsqueda
1.
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
Am J Gastroenterol
; 108(12): 1891-900, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24126633
2.
Treatment of Crohn's disease with certolizumab pegol.
Expert Rev Clin Immunol
; 3(5): 683-94, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20477019
Resultados
1 -
2
de 2
1
Próxima >
>>